Previous 10 | Next 10 |
Thomson Reuters ONE news releases related Thomson Reuters One news releases and Thomson Reuters One press releases from 07/31/20 02:00:10 on US and Canada...
NEW YORK and LONDON, July 31, 2020 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, is pleased to ann...
Montrouge, France, July 31, 2020 DBV Technologies Reports First Half 2020 Financial Results DBV Technologies (Euronext: DBV – ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today reported first half 2020 financial results. The interim ...
DUBLIN, Ireland, July 30, 2020 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage company with expertise in protein dysregulation and a diverse pipeleine of investigational therapeutics for neurodegenerative and rare peripheral amyloid diseases, announced today that i...
Another Call Center Automation milestone for Jacada having received placement in two Gartner Magic Quadrants in 2020 for both Workforce Engagement Management (WEM) and now Robotic Process Automation (RPA) ATLANTA, July 30, 2020 (GLOBE NEWSWIRE) -- Jacada, Inc., a global pioneer in custome...
Another Call Center Automation milestone for Jacada having received placement in two Gartner Magic Quadrants in 2020 for both Workforce Engagement Management (WEM) and now Robotic Process Automation (RPA) ATLANTA, July 30, 2020 (GLOBE NEWSWIRE) -- Jacada, Inc., a global pioneer in custome...
ISG Provider Lens™ report finds U.K. companies looking to service providers to help them move SAP tools to the cloud LONDON, U.K., July 30, 2020 (GLOBE NEWSWIRE) -- U.K. enterprises are delaying plans to adopt SAP’s S/4HANA intelligent ERP system due to continuing questions ab...
~ Entered into Exclusive Global License Agreement with CSL Behring for Development and Commercialization of uniQure’s Gene Therapy Candidate for Hemophilia B ~ ~ Completed First Patient Dosing in Phase I/II Clinical Trial of AMT-130 in Huntington’s Disease ~ LEXINGTON, Mass. ...
The global Phase 2/3 study will enroll up to 270 patients with severe COVID-19 across 40 clinical sites; The study has been approved in the UK and Russia and is under review in Italy, Brazil and Mexico -- Enrollment in a parallel U.S. Phase 2 study in patients with severe COVID-19 is e...
– FDA authorization of IND for Phase 2 trial of EDP1815 in COVID-19 in the U.S.; data expected in 4Q 2020 – –Achieved regulatory and ethics authorization for Phase 2 dose ranging trial for EDP1815 in moderate psoriasis in the U.S., UK, and EU; trial initiation expected in ...
July 29, 2020 Philips receives 510(k) clearance from the FDA for its professional defibrillator (Tempus LS- Manual), now offering its remote monitor and defibrillator solution (Tempus ALS) to EMS customers in the U.S. Solution delivers real-time bidirectional data transfer for remote pa...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
7.23%Change Percent:
Iris Energy Limited Company Name:
IREN Stock Symbol:
NASDAQ Market:
irisenergy.co Website: